<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The aim of our study was to provide population-based data on incidence and prognosis of synchronous <z:e sem="disease" ids="C1332128" disease_type="Neoplastic Process" abbrv="">peritoneal carcinomatosis</z:e> and to evaluate predictors for its development </plain></SENT>
<SENT sid="1" pm="."><plain>Diagnosed in 1995-2008, 18,738 cases of primary <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> were included </plain></SENT>
<SENT sid="2" pm="."><plain>Predictors of <z:e sem="disease" ids="C1332128" disease_type="Neoplastic Process" abbrv="">peritoneal carcinomatosis</z:e> were analysed by multivariable logistic regression analysis </plain></SENT>
<SENT sid="3" pm="."><plain>Median survival in months was calculated by site of <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>In the study period, 904 patients were diagnosed with synchronous <z:e sem="disease" ids="C1332128" disease_type="Neoplastic Process" abbrv="">peritoneal carcinomatosis</z:e> (4.8% of total, constituting 24% of patients presenting with M1 disease) </plain></SENT>
<SENT sid="5" pm="."><plain>The risk of <z:e sem="disease" ids="C1332128" disease_type="Neoplastic Process" abbrv="">peritoneal carcinomatosis</z:e> was increased in case of advanced T stage [T4 vs. T1,2: odds ratio (OR) 4.7, confidence limits 4.0-5.6), advanced N stage [N0 vs. N1,2: OR 0.2 (0.1-0.2)], poor differentiation grade [OR 2.1 (1.8-2.5)], younger age [&lt;60 years vs. 70-79 years: OR 1.4 (1.1-1.7)], mucinous <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> [OR 2.0 (1.6-2.4)] and right-sided localisation of <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumour</z:e> [left vs. right: OR 0.6 (0.5-0.7)] </plain></SENT>
<SENT sid="6" pm="."><plain>Median survival of patients with peritoneum as single site of <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> remained dismal [1995-2001: 7 (6-9) months; 2002-2008: 8 (6-11) months], contrasting the improvement among patients with <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> [1995-2001: 8 (7-9) months; 2002-2008: 12 (11-14) months] </plain></SENT>
<SENT sid="7" pm="."><plain>To conclude, synchronous <z:e sem="disease" ids="C0346989" disease_type="Neoplastic Process" abbrv="">peritoneal metastases</z:e> from <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> are more frequent among younger patients and among patients with advanced T stage, mucinous <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, right-sided <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> that are poorly differentiated </plain></SENT>
<SENT sid="8" pm="."><plain>The prognosis of synchronous <z:e sem="disease" ids="C1332128" disease_type="Neoplastic Process" abbrv="">peritoneal carcinomatosis</z:e> remains poor with a median survival of 8 months and even worse if concomitant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> in other organs are present </plain></SENT>
</text></document>